Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Glorieux

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Cancer Communications (London, England)|July 11, 2019
Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cellsChristophe Glorieux, Peng Huang
Biological Chemistry|April 7, 2017
Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approachChristophe Glorieux, Pedro Buc Calderon
Antioxidants (Basel, Switzerland)|September 5, 2019
Cancer Cell Sensitivity to Redox-Cycling Quinones is Influenced by NAD(P)H: Quinone Oxidoreductase 1 PolymorphismChristophe Glorieux, Pedro Buc Calderon
Redox Biology|October 24, 2024
Targeting catalase in cancerChristophe Glorieux, Pedro Buc Calderon
Antioxidants & Redox Signaling|July 13, 2021
Vitamin C (Ascorbate) and Redox Topics in CancerChristophe Glorieux, Pedro Buc Calderon
Cancer Cell International|February 23, 2018
Catalase down-regulation in cancer cells exposed to arsenic trioxide is involved in their increased sensitivity to a pro-oxidant treatmentChristophe Glorieux, Pedro Buc Calderon
Cancers|September 10, 2021
The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in CancerChristophe Glorieux, Xiaojun Xia, Peng Huang
Biochemical Pharmacology|December 21, 2024
The complex interplay between redox dysregulation and mTOR signaling pathway in cancer: A rationale for cancer treatmentChristophe Glorieux, Cinthya Enríquez, Pedro Buc Calderon
Biochemical Pharmacology|April 15, 2019
Targeting hsp90 family members: A strategy to improve cancer cell deathPedro Buc Calderon, Raphaël Beck, Christophe Glorieux
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 2018
Glucose-regulated protein of 94 kDa contributes to the development of an aggressive phenotype in breast cancer cellsPedro Buc Calderon, Anne-Laure Sennesael, Christophe Glorieux
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Cancer Communications (London, England)|July 11, 2019
Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cellsChristophe Glorieux, Peng Huang
Biological Chemistry|April 7, 2017
Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approachChristophe Glorieux, Pedro Buc Calderon
Antioxidants (Basel, Switzerland)|September 5, 2019
Cancer Cell Sensitivity to Redox-Cycling Quinones is Influenced by NAD(P)H: Quinone Oxidoreductase 1 PolymorphismChristophe Glorieux, Pedro Buc Calderon
Redox Biology|October 24, 2024
Targeting catalase in cancerChristophe Glorieux, Pedro Buc Calderon
Antioxidants & Redox Signaling|July 13, 2021
Vitamin C (Ascorbate) and Redox Topics in CancerChristophe Glorieux, Pedro Buc Calderon
Cancer Cell International|February 23, 2018
Catalase down-regulation in cancer cells exposed to arsenic trioxide is involved in their increased sensitivity to a pro-oxidant treatmentChristophe Glorieux, Pedro Buc Calderon
Cancers|September 10, 2021
The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in CancerChristophe Glorieux, Xiaojun Xia, Peng Huang
Biochemical Pharmacology|December 21, 2024
The complex interplay between redox dysregulation and mTOR signaling pathway in cancer: A rationale for cancer treatmentChristophe Glorieux, Cinthya Enríquez, Pedro Buc Calderon
Biochemical Pharmacology|April 15, 2019
Targeting hsp90 family members: A strategy to improve cancer cell deathPedro Buc Calderon, Raphaël Beck, Christophe Glorieux
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 2018
Glucose-regulated protein of 94 kDa contributes to the development of an aggressive phenotype in breast cancer cellsPedro Buc Calderon, Anne-Laure Sennesael, Christophe Glorieux
Pageof 4